Abstract: The present disclosure is drawn to oral pharmaceutical compositions and dosage forms containing select lipobalanced testosterone prodrugs and related methods. In one embodiment of the present invention, an oral pharmaceutical composition for administration to subjects in need of testosterone is provided. The composition comprises a lipobalanced testosterone prodrugs and a pharmaceutically acceptable carrier.

Abstract: In summary there is provided in one embodiment a a bundle of pans and a handle. The handle has opposed adhesive ends and an un-adhesive portion between the two adhesive ends. The adhesive sections extend such that each adhesive section lies over at least a section of an opposing pan side defined on outside surfaces of the lower most pan and a height defined by the rims of the bundle of pans. The un-adhesive portion of the handle rests at least along a portion of the opposing uppermost sidewalls of the uppermost pan and the bottom base of the uppermost pan and is configured to act as a handle when pulled taut.

Abstract: In summary there is provided in one embodiment a combination of a pan with roasting material used in cooking food. The pan is configured for use to cook food and includes a bottom base having a base periphery edge and a sidewall extending upwardly from the base periphery edge and terminating at a side edge to create a well therebetween. The roasting material is removably secured to the bottom base or the sidewall of the pan. In addition, the roasting material is configured for use in conjunction with the pan to cook food and wherein the roasting material is either a roasting bag and a roasting bag tie for use together with each other, or aluminum foil, such that the roasting material is removed from the bottom base of the pan and used in conjunction with the pan to cook food.

Abstract: The present disclosure is drawn to oral pharmaceutical compositions and dosage forms containing select testosterone esters and related methods. In one embodiment of the present invention, an oral pharmaceutical composition for administration to subjects in need of testosterone is provided. The composition comprises a testosterone ester and a pharmaceutically acceptable carrier. The testosterone ester can have the structure wherein R is —C13H25O or —C14H27O. One or both of the esters can be present in the pharmaceutical composition. The composition is formulated such that upon single dose administration to a group of human subject, the composition provides a mean serum testosterone Cavg t12-t24 that is within about 35% to about 70% of the mean serum testosterone Cavg t0-424.

Abstract: The present disclosure is drawn to oral pharmaceutical compositions and dosage forms containing select testosterone esters and related methods. In one embodiment of the present invention, an oral pharmaceutical composition for administration to subjects in need of testosterone is provided. The composition comprises a testosterone ester and a pharmaceutically acceptable carrier. The testosterone ester can have the structure wherein R is —C13H25O or —C14H27O. One or both of the esters can be present in the pharmaceutical composition. The composition is formulated such that upon single dose administration to a group of human subject, the composition provides a mean serum testosterone Cavg t12-t24 that is within about 35% to about 70% of the mean serum testosterone Cavg t0-t24.

Abstract: In summary there is provided in one embodiment a combination of a pan with a box for holding a roasting material. The roasting bag is positioned within and removable from the box.

Abstract: In summary there is provided in one embodiment a combination of a pan with roasting material used in cooking food.

Abstract: A dynamic responsive acoustic tuning envelope system that includes a movably connected set of cells, each possessing sound reflecting, sound absorbing, and/or electro-acoustic properties, and which are assembled according to the principles of rigid origami. So configured, the system is capable of both localized surficial deformation to alter the material surface exposure, transform its textural profile, and alter the enclosed volume of space in a single material envelope, thereby tuning the acoustics of the environment in which the system resides.

Abstract: The invention provides a method for the production of a metal, the method comprising the steps of mixing an oxide of the metal with a reducing agent comprising a Group II metal or a hydride thereof in the presence of water and/or an organic solvent, heating the mixture of oxide and reducing agent, leaching the resulting material with water; and washing the leached material with a dilute aqueous acid. Typically, the metal is a transition or rare earth metal, the oxide of the metal is an oxide of a transition or rare earth metal, and the reducing agent is selected from calcium or magnesium or the hydrides of calcium and magnesium. The metal is generally obtained at a purity of around 98.5-99.1%, and the method is much quicker than the methods of the prior art and has a much lower carbon footprint, thereby providing an option which is more sustainable, environmentally friendly, and accommodative for industries.

Abstract: There is provided a combination of nested pans for use in warming and cooking foods. The combination includes a first pan and a second pan. The second pan has a base portion terminating to an upwardly extending continuously surrounding sidewall. The sidewall has an upper edge that extend outwardly to a rim. The second pan further has an inside angle defined between the base portion of the upwardly extending sidewall, and wherein the continuously surrounding sidewall defines a pair of oppositely positioned short sides and a pair of oppositely positioned long sides interspaced between the short sides. The length of the short side of the pan is configured to permit at least three pans to nest side by side within the first pan.

Abstract: A dynamic responsive acoustic tuning envelope system that includes a movably connected set of cells, each possessing sound reflecting, sound absorbing, and/or electro-acoustic properties, and which are assembled according to the principles of rigid origami. So configured, the system is capable of both localized surficial deformation to alter the material surface exposure, transform its textural profile, and alter the enclosed volume of space in a single material envelope, thereby tuning the acoustics of the environment in which the system resides.

Abstract: In summary there is provided in one embodiment a combination of a pan with a box for holding a roasting material. The roasting bag is positioned within and removable from the box.

Abstract: In summary there is provided in one embodiment a combination of a pan with a label for holding a roasting bag. The pan is defined by having a bottom base having a base periphery edge and a sidewall extending upwardly from the base periphery edge and terminating at a side edge to create a well therebetween. The label includes front and rear sides. The rear side being secured to the bottom base and includes a pocket formed thereon. The pocket has an access opening into an internal space of the pocket. The roasting bag is positioned within and removable from the pocket of the label.

Abstract: The present disclosure is drawn to oral pharmaceutical compositions and dosage forms containing select testosterone esters and related methods. In one embodiment of the present invention, an oral pharmaceutical composition for administration to subjects in need of testosterone is provided. The composition comprises a testosterone ester and a pharmaceutically acceptable carrier. The testosterone ester can have the structure wherein R is —C13H25O or —C14H27O. One or both of the esters can be present in the pharmaceutical composition. The composition is formulated such that upon single dose administration to a group of human subject, the composition provides a mean serum testosterone Cavg t12-t24 that is within about 35% to about 70% of the mean serum testosterone Cavg t0-t24.

Abstract: The present disclosure is drawn to oral pharmaceutical compositions and dosage forms containing select testosterone esters and related methods. In one embodiment of the present invention, an oral pharmaceutical composition for administration to subjects in need of testosterone is provided. The composition comprises a testosterone ester and a pharmaceutically acceptable carrier. The testosterone ester can have the structure wherein R is —C13H25O or —C14H27O. One or both of the esters can be present in the pharmaceutical composition. The composition is formulated such that upon single dose administration to a group of human subject, the composition provides a mean serum testosterone Cavg t12-t24 that is within about 35% to about 70% of the mean serum testosterone Cavg t0-t24.

Abstract: The present disclosure is drawn to oral pharmaceutical compositions and dosage forms containing select testosterone esters and related methods. In one embodiment of the present invention, an oral pharmaceutical composition for administration to subjects in need of testosterone is provided. The composition comprises a testosterone ester and a pharmaceutically acceptable carrier. The testosterone ester can have the structure wherein R is —C13H25O or —C14H27O. One or both of the esters can be present in the pharmaceutical composition. The composition is formulated such that upon single dose administration to a group of human subject, the composition provides a mean serum testosterone Cavg t12-t24 that is within about 35% to about 70% of the mean serum testosterone Cavg t0-t24.

Abstract: There is provided a packaged pan and lid that includes at least two nested pans and at least two lids. Each lid has at least two bi-lateral fold lines, such that the lid is configurable into a folded configuration and removable secured within a well of a corresponding pan. The lid being removable from the well and unfolded to a substantially flat configuration. The lid may then be placed on the rim of the pan, such that a lip of the pan can be bent over the edge of the lid.

Abstract: The present disclosure is drawn to oral pharmaceutical compositions and dosage forms containing select lipobalanced testosterone prodrugs and related methods. In one embodiment of the present invention, an oral pharmaceutical composition for administration to subjects in need of testosterone is provided. The composition comprises a lipobalanced testosterone prodrugs and a pharmaceutically acceptable carrier.